Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles

被引:122
作者
Tiyaboonchai, Waree [1 ]
Limpeanchob, Nanteetip
机构
[1] Naresuan Univ, Dept Pharmaceut Technol, Phitsanulok 65000, Thailand
[2] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Phitsanulok 65000, Thailand
关键词
amophotericin B; chitosan; dextran sulfate; nanoparticles;
D O I
10.1016/j.ijpharm.2006.08.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A new nanoparticulate delivery system for amphotericin B (AmB) has been developed by means of the polyelectrolyte complexation technique. Two opposite charged polymers were used to form nanoparticles through electrostatic interaction, chitosan (CH) as a positively charged polymer and dextran sulfate (DS) as a polymer with a negative charge, together with zinc sulfate as a crosslinking and hardening agent. The AmB nanoparticles obtained possessed a mean particle size of 600-800 nm with a polydispersity index of 0.2, indicating a narrow size distribution. The measured zeta potential of the nanoparticle surface was approximately -32 mV indicating a strong negative charge at the particle's surface. Scanning electron microscopy revealed spherical particles with a smooth surface. Drug association efficacy of up to 65% was achieved. Dissolution studies demonstrated a fast release behavior suggesting that AmB exhibits only moderate interaction with the weakly crosslinked polymers of the nanoparticles. Although, electronic absorbance spectra showed that the aggregation state of AmB was modified within the nanoparticles, a reduction of nephrotoxicity was observed in an in vivo renal toxicity study. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:142 / 149
页数:8
相关论文
共 24 条
[1]  
[Anonymous], [No title captured]
[2]   EFFECTS OF THE AGGREGATION STATE OF AMPHOTERICIN-B ON ITS TOXICITY TO MICE [J].
BARWICZ, J ;
CHRISTIAN, S ;
GRUDA, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) :2310-2315
[3]   INTERACTION BETWEEN PHOSPHOLIPID-BILAYER MEMBRANES AND THE POLYENE ANTIBIOTIC AMPHOTERICIN-B - LIPID STATE AND CHOLESTEROL CONTENT DEPENDENCE [J].
BOLARD, J ;
SEIGNEURET, M ;
BOUDET, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 599 (01) :280-293
[4]   AmBisome (Liposomal amphotericin B): A comparative review [J].
Boswell, GW ;
Buell, D ;
Bekersky, I .
JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (07) :583-592
[5]   PRACTICAL ANALYSIS OF COMPLEX COACERVATE SYSTEMS [J].
BURGESS, DJ .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1990, 140 (01) :227-238
[6]   INFRARED-ABSORPTION AND RAMAN-SCATTERING OF SULFATE GROUPS OF HEPARIN AND RELATED GLYCOSAMINOGLYCANS IN AQUEOUS-SOLUTION [J].
CABASSI, F ;
CASU, B ;
PERLIN, AS .
CARBOHYDRATE RESEARCH, 1978, 63 (JUN) :1-11
[7]   Polymeric carriers for amphotericin B:: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice [J].
Espuelas, MS ;
Legrand, P ;
Campanero, MA ;
Appel, M ;
Chéron, M ;
Gamazo, C ;
Barratt, G ;
Irache, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (03) :419-427
[8]   IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF AMPHOTERICIN-B IN HUMAN-SERUM AND PLASMA [J].
HOSOTSUBO, H ;
HOSOTSUBO, K .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (08) :975-979
[9]  
Illum L, 1998, PHARM RES-DORDR, V15, P1326